Profile | GDS5420 / 223254_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 371.54 | 62 |
GSM1296119 | B_lesional_pre-dose | 701.25 | 74 |
GSM1296076 | C_lesional_pre-dose | 272.27 | 59 |
GSM1296092 | D_lesional_pre-dose | 261.77 | 58 |
GSM1296103 | E_lesional_pre-dose | 392.27 | 63 |
GSM1296078 | F_lesional_pre-dose | 207.18 | 55 |
GSM1296107 | G_lesional_pre-dose | 805.59 | 76 |
GSM1296109 | H_lesional_pre-dose | 741.13 | 74 |
GSM1296080 | I_lesional_pre-dose | 197.61 | 53 |
GSM1296090 | J_lesional_pre-dose | 315.68 | 61 |
GSM1296074 | K_lesional_pre-dose | 366.07 | 64 |
GSM1296111 | L_lesional_pre-dose | 795.31 | 76 |
GSM1296099 | M_lesional_pre-dose | 287.2 | 58 |
GSM1296086 | O_lesional_pre-dose | 257.95 | 58 |
GSM1296117 | P_lesional_pre-dose | 691.58 | 73 |
GSM1296113 | Q_lesional_pre-dose | 1023.4 | 80 |
GSM1296096 | R_lesional_pre-dose | 309.35 | 60 |
GSM1296105 | S_lesional_pre-dose | 341.85 | 61 |
GSM1296098 | T_lesional_pre-dose | 415.51 | 64 |
GSM1296101 | U_lesional_pre-dose | 354.62 | 61 |
GSM1296121 | V_lesional_pre-dose | 764.47 | 75 |
GSM1296088 | W_lesional_pre-dose | 329.52 | 61 |
GSM1296082 | X_lesional_pre-dose | 278.73 | 59 |
GSM1296115 | Y_lesional_pre-dose | 615.77 | 71 |
GSM1296084 | Z_lesional_pre-dose | 395.71 | 64 |
GSM1296072 | B_lesional_day8 | 657.35 | 72 |
GSM1296069 | L_lesional_day8 | 794.15 | 76 |
GSM1296071 | P_lesional_day8 | 794.86 | 76 |
GSM1296070 | Y_lesional_day8 | 770.9 | 75 |
GSM1296073 | V_lesional_day8 | 739.23 | 75 |
GSM1296034 | A_lesional_day15 | 342.7 | 60 |
GSM1296041 | G_lesional_day15 | 632.38 | 72 |
GSM1296035 | R_lesional_day15 | 394.53 | 63 |
GSM1296038 | U_lesional_day15 | 358.6 | 62 |
GSM1296047 | B_lesional_day15 | 607.8 | 71 |
GSM1296039 | E_lesional_day15 | 316.33 | 60 |
GSM1296042 | H_lesional_day15 | 543.91 | 69 |
GSM1296043 | L_lesional_day15 | 752.32 | 75 |
GSM1296037 | M_lesional_day15 | 363.03 | 62 |
GSM1296046 | P_lesional_day15 | 834.84 | 76 |
GSM1296044 | Q_lesional_day15 | 947.14 | 79 |
GSM1296045 | Y_lesional_day15 | 808.43 | 76 |
GSM1296025 | C_lesional_day15 | 337.58 | 61 |
GSM1296033 | D_lesional_day15 | 205.03 | 53 |
GSM1296027 | I_lesional_day15 | 119.48 | 46 |
GSM1296032 | J_lesional_day15 | 193.21 | 52 |
GSM1296024 | K_lesional_day15 | 401.97 | 64 |
GSM1296031 | W_lesional_day15 | 384.18 | 63 |
GSM1296028 | X_lesional_day15 | 176.66 | 51 |
GSM1296029 | Z_lesional_day15 | 273.68 | 57 |
GSM1296026 | F_lesional_day15 | 169.79 | 51 |
GSM1296030 | O_lesional_day15 | 201.88 | 54 |
GSM1296040 | S_lesional_day15 | 289.16 | 58 |
GSM1296036 | T_lesional_day15 | 451.48 | 65 |
GSM1296048 | V_lesional_day15 | 667.81 | 73 |
GSM1296059 | A_lesional_day43 | 255.77 | 57 |
GSM1296066 | G_lesional_day43 | 750.02 | 75 |
GSM1296060 | R_lesional_day43 | 306.94 | 59 |
GSM1296063 | U_lesional_day43 | 329.22 | 61 |
GSM1296064 | E_lesional_day43 | 486.48 | 68 |
GSM1296067 | H_lesional_day43 | 722.31 | 74 |
GSM1296062 | M_lesional_day43 | 363.83 | 62 |
GSM1296068 | Q_lesional_day43 | 1050.2 | 80 |
GSM1296050 | C_lesional_day43 | 253.77 | 57 |
GSM1296057 | D_lesional_day43 | 373.92 | 62 |
GSM1296052 | I_lesional_day43 | 139.56 | 48 |
GSM1296054 | J_lesional_day43 | 323.24 | 60 |
GSM1296049 | K_lesional_day43 | 327.97 | 61 |
GSM1296055 | W_lesional_day43 | 371.41 | 62 |
GSM1296053 | X_lesional_day43 | 310.14 | 59 |
GSM1296058 | Z_lesional_day43 | 284.04 | 58 |
GSM1296051 | F_lesional_day43 | 235.94 | 56 |
GSM1296056 | O_lesional_day43 | 269.32 | 58 |
GSM1296065 | S_lesional_day43 | 317.17 | 60 |
GSM1296061 | T_lesional_day43 | 412.7 | 64 |
GSM1296095 | A_non-lesional_pre-dose | 564.75 | 70 |
GSM1296120 | B_non-lesional_pre-dose | 687.53 | 73 |
GSM1296077 | C_non-lesional_pre-dose | 355 | 62 |
GSM1296093 | D_non-lesional_pre-dose | 370.88 | 62 |
GSM1296104 | E_non-lesional_pre-dose | 427.4 | 65 |
GSM1296079 | F_non-lesional_pre-dose | 267.48 | 58 |
GSM1296108 | G_non-lesional_pre-dose | 943.05 | 78 |
GSM1296110 | H_non-lesional_pre-dose | 731.1 | 74 |
GSM1296081 | I_non-lesional_pre-dose | 230.89 | 56 |
GSM1296091 | J_non-lesional_pre-dose | 366.93 | 63 |
GSM1296075 | K_non-lesional_pre-dose | 333.16 | 62 |
GSM1296112 | L_non-lesional_pre-dose | 780.8 | 75 |
GSM1296100 | M_non-lesional_pre-dose | 370.82 | 62 |
GSM1296087 | O_non-lesional_pre-dose | 200.08 | 54 |
GSM1296118 | P_non-lesional_pre-dose | 917.6 | 78 |
GSM1296114 | Q_non-lesional_pre-dose | 1110.59 | 81 |
GSM1296097 | R_non-lesional_pre-dose | 330.76 | 61 |
GSM1296106 | S_non-lesional_pre-dose | 490.3 | 67 |
GSM1296102 | U_non-lesional_pre-dose | 493 | 67 |
GSM1296122 | V_non-lesional_pre-dose | 653.17 | 72 |
GSM1296089 | W_non-lesional_pre-dose | 398.39 | 63 |
GSM1296083 | X_non-lesional_pre-dose | 360.08 | 62 |
GSM1296116 | Y_non-lesional_pre-dose | 760.82 | 75 |
GSM1296085 | Z_non-lesional_pre-dose | 240.84 | 55 |